Ignite Creation Date:
2024-05-05 @ 7:33 PM
Last Modification Date:
2024-10-26 @ 9:50 AM
Study NCT ID:
NCT00692510
Status:
COMPLETED
Last Update Posted:
2008-11-26
First Post:
2008-05-29
Brief Title:
Drug Interaction Study Between AZD3480 and Cytochrome P450
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Study Overview
Official Title:
A Phase I Double Blind Randomized Two-Way Cross Over Single- Centre Study in Healthy CYP2D6 Extensive Metabolizers and Poor Metabolizers to Investigate the Potential of AZD3480 to Inhibit Cytochrome P450 1A2 2C19 3A4 2C8 2B6 and UGT1A1 Activity
Status:
COMPLETED
Status Verified Date:
2008-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
Cocktail
Brief Summary:
The purpose of the study is to evaluate if AZD3480 inhibits Cytochrome P450 1A2 2C19 3A4 2C8 2B6 and UGT1A1 activity
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| EudraCt nr 2007-002456-10 | None | None | None |